Topic mergers

News mergers

• Kentucky Bioprocessing, Icon Genetics and Mapp Biopharmaceutical have entered into discussions to merge their businesses

  Kentucky Bioprocessing, LLC (KBP), Icon  Genetics, GmbH (ICON) and Mapp Biopharmaceutical, Inc. (Mappbio) have announced that they have entered into detailed negotiations aimed at merging the companies to create a single, fully integrated biopharmaceutical discovery, development and manufacturing en more

• Merger of Probiomics and Hunter Immunology to Speed Development of Promising New Vaccine

  Hunter Immunology recommended shareholders accept the takeover offer from listed biotech Probiomics. The Company’s four largest shareholders, respected funds manager Chris Cuffe, investment group Intersuisse Biosciences and co-founders Dr Philip Comans and Professor Robert Clancy, who together hold more

• CryoLife Announces Completion of Acquisition of Cardiogenesis

  CryoLife, Inc.  announced that it has successfully completed its acquisition of Cardiogenesis Corporation.The acquisition of Cardiogenesis adds to the company's portfolio a surgical product used in the treatment of diffuse coronary artery disease and severe angina. Cardiogenesis had sales of approxi more

White papers mergers

• Outsourcing R&D Innovation takes on New Meaning
  

  Innovative drugs are the lifeblood of pharmaceutical companies, but the cost of developing them is rising to unsustainable levels. Pharma executives are already saying that as the economy falters, they foresee bleak prospects and mergers unless their companies get more innovative drugs into their pipelines. The clock is ticking on the race to increase productivity, as key patents worth a projected $30 billion in revenue will expire between 2010 and 2013, opening the floodgates to competition from generics, according to Barbara Ryan, an analyst at Deutsche Bank. This imperative is propelling increased outsourcing of R&D operations as companies trim overcapacity. more

Publications mergers

• Direct formation of supermassive black holes via multi-scale gas inflows in galaxy mergers

  Direct formation of supermassive black holes via multi-scale gas inflows in galaxy mergers Nature 466, 1082 (2010). doi:10.1038/nature09294 Authors: L. Mayer, S. Kazantzidis, A. Escala & S. Callegari Observations of distant quasars indicate that supermassive black holes of billions of sola more

• The impact of mergers on pharmaceutical R&D

  The impact of mergers on pharmaceutical R&D Nature Reviews Drug Discovery 10, 559 (2011). doi:10.1038/nrd3514 Author: John L. LaMattina Mergers and acquisitions in the pharmaceutical industry have substantially reduced the number of major companies over the past 15 years. The more

• [Perspective] Astronomy: A Tale of Two Jets

  Numerical models suggest that black hole mergers may produce a strong, potentially detectable electromagnetic counterpart to their emitted gravitational waves. more

Market studies mergers

• Non-Small Cell Lung Cancer – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Non-Small Cell Lung Cancer - Pipeline Review, H1 2012', provides an overview of the Non-Small Cell Lung Cancer therapeutic pipeline. This report provides information on the therapeutic development for Non-Small Cell Lung Cancer, complete with latest updates, more

• Hemophilia – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Hemophilia - Pipeline Review, H1 2012', provides an overview of the Hemophilia therapeutic pipeline. This report provides information on the therapeutic development for Hemophilia, complete with latest updates, and special features on late-stage and discontin more

• Schizophrenia – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'Schizophrenia - Pipeline Review, H1 2012', provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the therapeutic development for Schizophrenia, complete with latest updates, and special features on late-stage and more

Websites mergers